Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Globe and Mail, The
That is the winning formula behind the new Clinical Support and Research Centre (CSRC) that adjoins St. Paul's Hospital on the Jim Pattison Medical Campus in downtown Vancouver, set to begin construction this time next year. The project's total capital cost of about $638-million will be shared by the province (nearly $332-million), Providence Health Care ($215-million), St. Paul's Foundation ($88-million), and ChildCare BC New Spaces Program ($3-million). “The new hospital is already up to the 10th floor,” says Fiona Dalton, president and chief executive officer of Providence Health Care. “The CSRC building is the other side of the coin. … We need to catch up. I've always believed that anywhere in the world where health care delivery and innovation of new science practices exist together, magic happens.” The purpose-built 370,000-square-foot facility features a two-storey sky bridge connecting the hospital to the 12-storey CSRC. After competitive requests for proposals, PCL Co
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024Business Wire
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024Business Wire
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024Business Wire
ABCL
Earnings
- 2/20/24 - Miss
ABCL
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- ABCL's page on the SEC website